Akari Therapeutics PLC
F:CLA
Akari Therapeutics PLC
F:CLA
Price:
0.0556
EUR
Market Closed
Market Cap:
€198.7m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Akari Therapeutics PLC
F:CLA
|
US |
|
S
|
Sankyu Inc
F:SNK
|
JP |
|
H
|
HEC Infra Projects Ltd
NSE:HECPROJECT
|
IN |
|
Y
|
Yoc AG
DUS:YOC
|
DE |
|
Instalco AB
F:4IIA
|
SE |
|
F
|
Filinvest REIT Corp
XPHS:FILRT
|
PH |
|
Innocan Pharma Corp
F:IP4
|
IL |
|
I
|
Innocan Pharma Corp
XHAM:IP4
|
IL |
|
A
|
Actic Group AB
STO:ATIC
|
SE |
|
S4 Capital PLC
LSE:SFOR
|
UK |
|
F
|
Fervo Energy Co
NASDAQ:FRVO
|
US |
Multiples-Based Value
There is not enough data to reliably calculate the multiples-based value of CLA.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
CLA
Multiples-Based Value
Base Case
Not Available
